Factors affecting quality of life in epidermolysis bullosa

References

• Fine JD, Johnson LB, Suchindran C et al. The epidemiology of inherited EB: findings within American, Canadian, and European study populations. In: Epidermolysis Bullosa: Clinical, Epidemiologic, and Laboratory Advances, and the Findings of the National Epidermolysis Bullosa Registry. Fine JD, Bauer EA, McGuire J, Moshell A (Eds). Johns Hopkins University Press, MD, USA 101–113 (1999).
   Google Scholar
• Horn HM, Priestley GC, Eady RA, Tidman MJ. The prevalence of epidermolysis bullosa in Scotland. Br. J. Dermatol.136(4), 560–564 (1997).
   PubMed Web of Science ®Google Scholar
• McKenna KE, Walsh MY, Bingham EA. Epidermolysis bullosa in Northern Ireland. Br. J. Dermatol.127, 318–321 (1992).
   PubMed Web of Science ®Google Scholar
• Kero M. Occurrence of epidermolysis bullosa in Finland. Acta Derm. Venereol.64, 57–62 (1984).
   PubMed Web of Science ®Google Scholar
• Pavicic Z, Kmet-Vizintin P, Kansky A, Dobric I. Occurrence of hereditary bullosa epidermolyses in Croatia. Paediatr. Dermatol.7, 108–110 (1990).
   PubMed Web of Science ®Google Scholar
• Tadini G, Gualandri L, Colombi M et al. The Italian registry of hereditary epidermolysis bullosa. G Ital. Dermatol. Venereol.140, 359–372 (2005).
   Google Scholar
• Langan SM, Williams HC. A systematic review of randomized controlled trials of treatments for inherited forms of epidermolysis bullosa. Clin. Exp. Dermatol.34(1), 20–25 (2009).
   PubMed Web of Science ®Google Scholar
• Tolar J, Ishida-Yamamoto A, Riddle M et al. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood113(5), 1167–1174 (2009).
   PubMed Web of Science ®Google Scholar
• Chino T, Tamai K, Yamazaki T et al. Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Am. J. Pathol.173(3), 803–814 (2008).
   PubMed Web of Science ®Google Scholar
• De Luca M, Pellegrini G, Mavilio F. Gene therapy of inherited skin adhesion disorders: a critical overview. Br. J. Dermatol.161(1), 19–24 (2009).
   PubMed Web of Science ®Google Scholar
• Fine JD, Eady RA, Bauer EA et al. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J. Am. Acad. Dermatol.58(6), 931–950 (2008).
   PubMed Web of Science ®Google Scholar
• Fine JD, Johnson LB, Weiner M, Suchindran C. Cause-specific risks of childhood death in inherited epidermolysis bullosa. J. Pediatr.152(2), 276–280 (2008).
   PubMed Web of Science ®Google Scholar
• Wright JT. Oral manifestations in the epidermolysis bullosa spectrum. Dermatol. Clin.28(1), 159–164 (2010).
   PubMed Web of Science ®Google Scholar
• Shivaswamy KN, Sumathy TK, Shyamprasad AL, Ranganathan C. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl. Int. J. Dermatol.48(7), 731–733 (2009).
   PubMed Web of Science ®Google Scholar
• Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986–2006. J. Am. Acad. Dermatol.60(2), 203–211 (2009).
   PubMed Web of Science ®Google Scholar
• Souza CS, Felício LB, Bentley MV et al. Topical photodynamic therapy for Bowen’s disease of the digit in epidermolysis bullosa. Br. J. Dermatol.153(3), 672–674 (2005).
   PubMed Web of Science ®Google Scholar
• Arnold AW, Bruckner-Tuderman L, Zuger C, Itin PH. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa. Dermatology219(1), 80–83 (2009).
   PubMed Web of Science ®Google Scholar
• Saxena A, Lee JB, Humphreys TR. Mohs micrographic surgery for squamous cell carcinoma associated with epidermolysis bullosa. Dermatol. Surg.32(1), 128–134 (2006).
   PubMed Web of Science ®Google Scholar
• Fine JD. Possible role for sentinel node biopsy in the management of squamous cell carcinomas in inherited epidermolysis bullosa. Arch. Dermatol.140, 1012–1013 (2004).
   PubMedGoogle Scholar
• Rokunohe A, Nakano H, Aizu T et al. Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa. J. Dermatol.35(6), 336–340 (2008).
   PubMed Web of Science ®Google Scholar
• Perez-Naranjo L, Herrera-Saval A, Garcia-Bravo B, Perez-Bernal AM, Camacho F. Sentinel lymph node biopsy in recessive dystrophic epidermolysis bullosa and squamous cell carcinoma. Arch. Dermatol.141(1), 110–111 (2005).
   PubMedGoogle Scholar
• Fine JD, Johnson LB, Weiner M, Stein A, Suchindran C. Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a Phase 1 trial of systemic isotretinoin. J. Am. Acad. Dermatol.50(4), 563–571 (2004).
   PubMed Web of Science ®Google Scholar
• Moss C, Wong A, Davies P. The Birmingham Epidermolysis Bullosa Severity Score: development and validation. Br. J. Dermatol.160(5), 1057–1065 (2009).
   PubMed Web of Science ®Google Scholar
• WHOQOL Group. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc. Sci. Med..41, 1403–1409 (1995).
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Coulter A, Wright L. Short form 36 (SF-36) health survey questionnaire: normative data for adults of working age. BMJ306, 1437–1440 (1993).
   PubMed Web of Science ®Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin. Exp. Dermatol.19, 210–216 (1994).
   PubMed Web of Science ®Google Scholar
• Chren MM, Lasek RJ, Flocke SA et al. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin disease. Arch. Dermatol.133, 1433–1440 (1997).
   PubMed Web of Science ®Google Scholar
• Chren MM, Lasek RJ, Quinn LM, Covinsky KE. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J. Invest. Dermatol.108, 103–107 (1997).
   PubMed Web of Science ®Google Scholar
• EuroQol – a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy16, 199–208 (1990).
   PubMed Web of Science ®Google Scholar
• Dietz MJ. A day in the life of a patient with DDEB. J. Am. Acad. Dermatol.51(1 Suppl.), S58–S59 (2004).
   PubMed Web of Science ®Google Scholar
• Hall S. Life, epidermolysis bullosa and chasing tornadoes. J. Wound Care13, 405–406 (2004).
   PubMedGoogle Scholar
• van Scheppingen C, Lettinga AT, Duipmans JC, Maathuis CG, Jonkman MF. Main problems experienced by children with epidermolysis bullosa: a qualitative study with semi-structured interviews. Acta Derm. Venereol.88(2), 143–150 (2008).
   PubMed Web of Science ®Google Scholar
• Banky JP, Sheridan AT, Storer EL, Marshman G. Successful treatment of epidermolysis bullosa pruriginosa with topical tacrolimus. Arch. Dermatol.140(7), 794–796 (2004).
   PubMedGoogle Scholar
• Calikoglu E, Anadolu R. Management of generalized pruritus in dominant dystrophic epidermolysis bullosa using low-dose oral cyclosporin. Acta Derm. Venereol.82(5), 380–382 (2002)
   PubMed Web of Science ®Google Scholar
• Fine JD, Johnson LB, Weiner M, Suchindran C. Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa. Clin. Exp. Dermatol.29(2), 122–127 (2004).
   PubMed Web of Science ®Google Scholar
• Andreoli E, Mozetta A, Angelo C, Paradisi M, Foglio Bonda PG. Epidermolysis bullosa. Psychological and psychosocial aspects. Dermatol. Psychosom.3, 77–81 (2002).
   Google Scholar
• Horn HM, Tidman MJ. Quality of life in epidermolysis bullosa. Clin. Exp. Dermatol.27(8), 707–710 (2002).
   PubMed Web of Science ®Google Scholar
• Frew JW, Murrell DF. Quality of life measurements in epidermolysis bullosa: tools for clinical research and patient care. Dermatol. Clin.28(1), 185–190 (2010).
   PubMed Web of Science ®Google Scholar
• Frew JW, Martin LK, Nijsten T, Murrell DF. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument. Br. J. Dermatol.161(6), 1323–1330 (2009).
   PubMed Web of Science ®Google Scholar
• Tabolli S, Sampogna F, Di Pietro C et al. Quality of life in patients with epidermolysis bullosa. Br. J. Dermatol.161(4), 869–877 (2009).
   PubMed Web of Science ®Google Scholar
• Sampogna F, Picardi A, Chren MM et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom. Med.66, 620–624 (2004).
   PubMed Web of Science ®Google Scholar
• Lansdown R, Atherton D, Dale A, Sproston S, Lloyd J. Practical and psychological problems for parents and children with epidermolysis bullosa. Child Care Health Dev.12, 251–256 (1986).
   PubMed Web of Science ®Google Scholar
• Fine JD, Johnson LB, Weiner M, Suchindran C. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size. Br. J. Dermatol.152(5), 1009–1014 (2005).
   PubMed Web of Science ®Google Scholar
• van Scheppingen C, Lettinga AT, Duipmans JC, Maathuis KG, Jonkman MF. The main problems of parents of a child with epidermolysis bullosa. Qual. Health Res.18(4), 545–556 (2008).
   PubMed Web of Science ®Google Scholar
• Fine JD. Epidermolysis bullosa. Application of epidemiologic principles to the study of a group of rare diseases via a disease registry. Dermatol. Clin.13(3), 659–670 (1995).
   PubMed Web of Science ®Google Scholar
• Fine JD, Johnson LB, Weiner M, Suchindran C. Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry. J. Pediatr. Gastroenterol. Nutr.46(2), 147–158 (2008).
   PubMed Web of Science ®Google Scholar
• Freeman EB, Köglmeier J, Martinez AE et al. Gastrointestinal complications of epidermolysis bullosa in children. Br. J. Dermatol.158(6), 1308–1314 (2008).
   PubMed Web of Science ®Google Scholar
• Fine JD, Hall M, Weiner M, Li KP, Suchindran C. The risk of cardiomyopathy in inherited epidermolysis bullosa. Br. J. Dermatol.159(3), 677–682 (2008).
   PubMed Web of Science ®Google Scholar
• Fine JD, Johnson LB, Weiner M, Suchindran C. Tracheolaryngeal complications of inherited epidermolysis bullosa: cumulative experience of the national epidermolysis bullosa registry. Laryngoscope117(9), 1652–1660 (2007).
   PubMed Web of Science ®Google Scholar
• Fine JD, Johnson LB, Weiner M et al. Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry. Am. J. Ophthalmol.138(2), 254–262 (2004).
   PubMed Web of Science ®Google Scholar
• Figueira EC, Murrell DF, Coroneo MT. Ophthalmic involvement in inherited epidermolysis bullosa. Dermatol. Clin.28(1), 143–152 (2010).
   PubMed Web of Science ®Google Scholar
• Chan SM, Dillon MJ, Duffy PG, Atherton DJ. Nephro-urological complications of epidermolysis bullosa in paediatric patients. Br. J. Dermatol.156(1), 143–147 (2007).
   PubMed Web of Science ®Google Scholar
• Burgu B, Duffy PG, Wilcox DT. Single-centre experience of genitourinary complications of epidermolysis bullosa. J. Pediatr. Urol.2(6), 583–586 (2006).
   PubMedGoogle Scholar
• Fine JD, Johnson LB, Weiner M et al. Genitourinary complications of inherited epidermolysis bullosa: experience of the national epidermylosis bullosa registry and review of the literature. J. Urol.172(5 Pt 1), 2040–2044 (2004).
   PubMed Web of Science ®Google Scholar
• Hata D, Miyazaki M, Seto S et al. Nephrotic syndrome and aberrant expression of laminin isoforms in glomerular basement membranes for an infant with Herlitz junctional epidermolysis bullosa. Pediatrics116(4), E601–E607 (2005).
   PubMed Web of Science ®Google Scholar
• Farhi D, Ingen-Housz-Oro S, Ducret F et al. Recessive dystrophic epidermolysis bullosa (Hallopeau-Siemens) with IgA nephropathy: 4 cases. Ann. Dermatol. Venereol.131(11), 963–967 (2004).
   PubMed Web of Science ®Google Scholar
• Fine JD, Johnson LB, Weiner M et al. Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry. Am. J. Kidney Dis.44(4), 651–660 (2004).
   PubMed Web of Science ®Google Scholar
• Fine JD. Epidermolysis Bullosa. In: Dermatology. Bolognia JL, Jorizzo JL, Rapini RP (Eds). Mosby, MO, USA 491–500 (2003).
   Google Scholar